Hauv kev txhim kho cov tshuaj tiv thaiv kab mob metabolic, puas muaj cov khoom siv uas tuaj yeem ua raws li kev noj qab haus huv ntawm kev tawm dag zog thiab kev yoo mov thaum tib lub sijhawm tiv thaiv kev ua haujlwm ntawm ntau lub cev? ATX-304 yog ib qho kev cog lus ntawm qhov ncauj me me-molecule AMPK agonist, suav tias yog tus neeg siv tshuaj muaj peev xwm hauv kev ua haujlwm ntawm "kev txhim kho metabolic." Kab lus no yuav muab cov lus qhia ntxiv txog qhov sib xyaw no.
ATX-304 yog dab tsi
ATX-304 hmoov, tseem hu ua O-304 , yog ib qho kev hais lus me me -molecule AMPK activator. AMPK (adenosine monophosphate-activated protein kinase) yog ib qho tseem ceeb tswj enzyme nyob rau hauv cellular zog metabolism, hnov lub zog raws li txoj cai thiab txhawb fatty acid oxidation, qabzib uptake, thiab mitochondrial muaj nuj nqi. Qhov sib xyaw no, los ntawm kev ua kom txoj hauv kev adenosine kinase, tuaj yeem txhim kho insulin rhiab heev, txhawb lub zog metabolism, txo cov rog rog, thiab tau pom cov roj cholesterol- txo qis thiab rog lub siab{12}} txhim kho cov teebmeem hauv kev tshawb fawb tsiaj. Tsis tas li ntawd, nws muaj kev tiv thaiv rau lub raum, txo cov mob raum raug mob los ntawm cov tshuaj xws li cisplatin. Cov kws tshawb fawb ntseeg tias nws muaj peev xwm ua tau raws li cov txiaj ntsig metabolic ntawm kev tawm dag zog lossis kev yoo mov thiab yog cov tshuaj muaj txiaj ntsig zoo rau "kev txhim kho metabolic." Tam sim no, nws yog tsuas yog siv rau hauv kev tshawb fawb ntawm metabolic syndrome, rog rog, ntshav qab zib hom 2, thiab lwm yam kab mob plawv thiab raum. Raws li ib qho ntawm thawj qhov kev tswj hwm qhov ncauj, txhua qhov nyob ib puag ncig AMPK activators, nws qhib qhov kev taw qhia tshiab hauv kev tswj hwm cov tshuaj metabolic thiab xav tias yuav siv rau hauv kev tshawb fawb thiab kev kho mob yav tom ntej kom ncua metabolic poob qis, txhim kho lub zog sib npaug, thiab txhawb kev noj qab haus huv. Yog tias koj tseem xav tau ATX-304, thov hu rau Xi'an Sonwu. Xi'an Sonwu Company tos ntsoov rau koj cov lus teb.
ATX-304 ua dab tsi
ATX-304 (tseem hu ua O-304) muab ntau yam txiaj ntsig zoo los ntawm kev ua kom AMP-activated protein kinase-tus core regulator ntawm cellular zog metabolism.
1. Txhim kho Metabolic Health:
Nws txhim kho cov ntshav qabzib thiab cov tshuaj insulin rhiab heev, pab txhim kho cov ntshav qab zib kom ruaj khov thiab tiv thaiv insulin tsis kam-ib qho tseem ceeb hauv hom 2 mob ntshav qab zib mellitus thiab metabolic syndrome.
2. Txhawb kom muaj roj hlawv thiab tswj qhov hnyav:
Los ntawm stimulating AMP-activated protein kinase, nws tsub kom fatty acid oxidation thiab lub zog siv, yog li txo lub cev rog thiab txhim kho lipid metabolism.
3. Kev tiv thaiv daim siab:
Cov kev tshawb fawb tsiaj tau pom tias nws tuaj yeem txo cov roj cholesterol thiab txo cov kab mob siab hepatic steatosis, qhia txog cov txiaj ntsig zoo hauv kev kho mob ntawm daim siab rog (NAFLD / NASH).
4. Kev them nyiaj yug rau raum ua haujlwm:
Nws tau qhia txog kev tiv thaiv lub raum los ntawm kev txhim kho mitochondrial kev ua haujlwm thiab cell resilience, txo cov mob raum raug mob los ntawm cov tshuaj nephrotoxic xws li cisplatin.
5. Txhim kho ntshav ncig thiab siv zog:
Nws txhim kho cov hlab ntsha peripheral thiab cov leeg nqaij lub zog metabolism, uas muaj txiaj ntsig zoo rau cov hlab plawv thiab cov leeg nqaij, tshwj xeeb tshaj yog nyob rau hauv metabolic thiab hnub nyoog - mob ntsig txog.
6. Cov txiaj ntsig ntawm kev ua kom lub cev qoj ib ce thiab kev txwv calorie: Vim tias AMPK ua kom zoo li cov teebmeem metabolic ntawm kev tawm dag zog lossis kev yoo mov, nws tau tshawb nrhiav los ua "metabolic amplifier" los txhim kho kev noj qab haus huv thiab kev ua haujlwm zoo yam tsis muaj kev cuam tshuam kev ua neej.
Nws sawv cev rau qhov kev cog lus tom ntej no -kev kho cov txheej txheem metabolic tsim los kho kev rog rog, ntshav qab zib, thiab kab mob plawv thiab lub raum los ntawm kev ua kom lub cev lub zog zoo dua qub- txoj kev tswj hwm.
Yog ATX-304 muaj kev nyab xeeb
Kev nyab xeeb ntawm ATX-304 tam sim no tau raug tshuaj xyuas los ntawm kev sim tshuaj. Raws li xyoo 2026, nws raug cais raws li kev tshawb nrhiav tshuaj.
1. Cov xwm txheej tam sim no ntawm Kev Nyab Xeeb Kev Nyab Xeeb
Human Trials: Lub compound tau ua tiav Phase I thiab Phase Ib qhov kev sim tshuaj. Cov ntawv ceeb toom los ntawm cov theem pib no qhia tau hais tias qhov sib xyaw ua ke tau txais txiaj ntsig zoo hauv cov neeg ua haujlwm noj qab haus huv thiab cov neeg mob ntshav qab zib hom 2 lossis rog dhau lub sijhawm luv (txog 28 hnub).
Phase II Clinical Trials in Progress: Txoj kev tshawb no tau nce mus rau Theem II los ntsuas nws cov txiaj ntsig thiab kev nyab xeeb nyob rau lub sijhawm ntev dua. Ib txoj kev tshawb nrhiav kev txhais lus ua tiav nyob rau lub Tsib Hlis 2025 tshwj xeeb tshuaj xyuas nws cov tshuaj pharmacokinetics thiab kev nyab xeeb hauv cov neeg mob rog thiab cov neeg mob ntshav qab zib.
2. Cov txiaj ntsig ntawm Kev Tshawb Fawb Txog Kev Nyab Xeeb Preclinical
Cov teebmeem ntawm qhov sib xyaw no ntawm cov kab mob metabolic thiab kab mob plawv tau raug sim siv ntau hom tsiaj, feem ntau cov nas.
Lub siab thiab Metabolic Health: Kev tshawb fawb luam tawm xyoo 2024 thiab 2025 tau pom tias nws txo qis oxidative kev nyuaj siab thiab daim siab fibrosis hauv cov qauv ua ntej, tsis muaj kev mob toxicity tseem ceeb. Cov kev tshawb fawb tau pom tias qhov sib xyaw no yog "kev txwv tsis pub nkag mus," txhais tau tias nws yog tsim los ua cov ntaub so ntswg xws li cov leeg thiab daim siab thaum tsis txhob nkag mus rau hauv lub hauv nruab nrab lub paj hlwb, uas yuav txo tau qhov kev pheej hmoo ntawm kev mob hlwb.
3. Ceev faj
Vim tias ATX-304 yog lub lauj kaub-AMPK activator (nws qhib txhua hom subtypes ntawm AMPK enzyme), cov kws tshawb fawb yuav saib xyuas rau qhov tshwj xeeb "tawm-pom" cuam tshuam rau hom tshuaj no:
Cov teeb meem plawv: Cov teebmeem ntawm ntev -lub sij hawm ntev AMPK ua rau ntawm cardiometabolism tseem muaj teeb meem, tab sis kev tshawb fawb tsiaj ntawm cov tshuaj no tau pom tseeb tias nws txhim kho cov hlab plawv.
Cov leeg nqaij metabolism: Vim tias nws ua raws li qee qhov cuam tshuam ntawm kev tawm dag zog, cov kws tshawb fawb yuav saib xyuas nws cov teebmeem ntawm cov protein synthesis lossis cov leeg nqaij atrophy, tab sis cov ntaub ntawv los ntawm 2026 qhia tias nws pab tswj lub cev nqaij daim tawv thaum poob phaus.
Vim tias qhov sib xyaw no cuam tshuam rau cov piam thaj thiab lipid metabolism, nws tuaj yeem cuam tshuam nrog lwm cov tshuaj metabolic.
Yog tias koj xav nug txog tus nqi ntawm ATX-304 capsule lossis lwm yam ntaub ntawv khoom, thov hu rau Xi'an Sonwu ncaj qha.
Email:sales@sonwu.com
Cov ntaub ntawv: https://feelgoodpal.com/blog/alfalfa/